Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$20 Mln
P/E Ratio
--
P/B Ratio
0.65
Industry P/E
--
Debt to Equity
-0.96
ROE
-0.97 %
ROCE
-0.77 %
Div. Yield
0 %
Book Value
--
EPS
-0.11
CFO
$-188.83 Mln
EBITDA
$-160.19 Mln
Net Profit
$-229.26 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Rain Therapeutics (RAIN)
| -- | 43.93 | -- | -- | -12.78 | -- | -- |
|
BSE Sensex
| 2.39 | 4.18 | 4.86 | 8.78 | 11.89 | 20.62 | 11.13 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
|
|---|---|---|
|
Rain Therapeutics (RAIN)
| -85.00 | -37.89 |
|
S&P Small-Cap 600
| 13.89 | -17.42 |
|
BSE Sensex
| 18.74 | 4.44 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 36.79 | 9,808.03 | 20.22 | 23.13 | |
| 289.41 | 8,956.09 | 22.08 | 58.42 | |
| 26.79 | 9,559.25 | -- | -28.77 | |
| 103.51 | 10,030.35 | 30.81 | 14.16 |
Rain Enhancement Technologies Holdco, Inc. develops, manufactures, and commercializes ionization rainfall generation technology. The company is based in Naples, Florida. Rain Enhancement Technologies Holdco, Inc. operates as a subsidiary of... Rainwater, LLC. Address: 1659 Chinaberry Ct., Naples, FL, United States, 34105 Read more
Co-Founder, CEO & Chairman
Mr. Avanish Vellanki M.B.A.
Co-Founder, CEO & Chairman
Mr. Avanish Vellanki M.B.A.
Headquarters
Naples, FL
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Rain Therapeutics Inc (RAIN) stood at $ 1 Mln as on 31-Dec-23
The share price of Rain Therapeutics Inc (RAIN) is $2.74 (NASDAQ) as of 23-Apr-2025 12:02 EDT. Rain Therapeutics Inc (RAIN) has given a return of -12.78% in the last 3 years.
Rain Therapeutics Inc (RAIN) has a market capitalisation of $ 20 Mln as on 22-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Rain Therapeutics Inc (RAIN) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Rain Therapeutics Inc (RAIN) and enter the required number of quantities and click on buy to purchase the shares of Rain Therapeutics Inc (RAIN).
Rain Enhancement Technologies Holdco, Inc. develops, manufactures, and commercializes ionization rainfall generation technology. The company is based in Naples, Florida. Rain Enhancement Technologies Holdco, Inc. operates as a subsidiary of Rainwater, LLC. Address: 1659 Chinaberry Ct., Naples, FL, United States, 34105
The CEO & director of Mr. Avanish Vellanki M.B.A.. is Rain Therapeutics Inc (RAIN), and CFO & Sr. VP is Mr. Avanish Vellanki M.B.A..
There is no promoter pledging in Rain Therapeutics Inc (RAIN).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,012
|
|
|
990
|
|
|
974
|
|
|
896
|
| Rain Therapeutics Inc. (RAIN) | Ratios |
|---|---|
|
Return on equity(%)
|
-0.78
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Rain Therapeutics Inc (RAIN) was $-65 Mln.
$0.21
(
